We applied our EASANA® platform to analyze the effect of estrogen treatments on the gene expression regulation at the exon level on a breast cancer cell line (collaboration with INSERM and the Curie Institute).


“Estrogen regulation and physiopathologic significance of alternative promoters in breast cancer.”

Dutertre M, Gratadou L, Dardenne E, Germann S, Samaan S, Lidereau R, Driouch K, de la Grange P, Auboeuf D.

Cancer Res. 2010 May 1;70(9):3760-70. Epub 2010 Apr 20. DOI, Pubmed

Categories: Article